Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia
Open Access
- 8 March 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3), e0173466
- https://doi.org/10.1371/journal.pone.0173466
Abstract
Polypharmacy has been associated with increased morbidity and mortality in the older population. The aim of this study was to determine the prevalence, risk factors and health outcomes associated with polypharmacy in a cohort of urban community-dwelling older adults receiving chronic medications in Malaysia. This was a baseline study in the Malaysian Elders Longitudinal Research cohort. The inclusion criteria were individuals aged ≥55years and taking at least one medication chronically (≥3 months). Participants were interviewed using a structured questionnaire during home visits where medications taken were reviewed. Health outcomes assessed were frequency of falls, functional disability, potential inappropriate medication use (PIMs), potential drug-drug interactions (PDDIs), healthcare utilisation and quality of life (QoL). Risk factors and health outcomes associated with polypharmacy (≥5 medications including dietary supplements) were determined using multivariate regression models. A total of 1256 participants were included with a median (interquartile range) age of 69(63–74) years. The prevalence of polypharmacy was 45.9% while supplement users made up 56.9% of the cohort. The risk factors associated with increasing medication use were increasing age, Indian ethnicity, male, having a higher number of comorbidities specifically those diagnosed with cardiovascular, endocrine and gastrointestinal disorders, as well as supplement use. Health outcomes significantly associated with polypharmacy were PIMS, PDDIs and increased healthcare utilisation. A significant proportion of older adults on chronic medications were exposed to polypharmacy and use of dietary supplements contributed significantly to this. Medication reviews are warranted to reduce significant polypharmacy related issues in the older population.Keywords
Funding Information
- High Impact Research Grant (UM.C/625/1/HIR/MOHE/ASH/02)
- University Malaya Research Grant (UMRG RP029-14HTM)
This publication has 75 references indexed in Scilit:
- Drug-related problems in type 2 diabetes mellitus patients with dyslipidemiaBMC Public Health, 2013
- Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective studyBMC Endocrine Disorders, 2013
- Executive Summary: Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Aging with multimorbidity: A systematic review of the literatureAgeing Research Reviews, 2011
- Correlates of Quality of Life in Older Adults With DiabetesDiabetes Care, 2011
- Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico BorderDrugs & Aging, 2009
- Appropriateness of Prescribing among Elderly Patients in a Dutch Residential HomeDrugs & Aging, 2008
- Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid DiseasesJama-Journal Of The American Medical Association, 2005
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969
- Studies of Illness in the AgedPublished by American Medical Association (AMA) ,1963